| Noreen Shaikh, MD | |
|
1 Essex Center Dr, Peabody, MA 01960-2901 | |
| (978) 538-4400 | |
| Not Available |
| Full Name | Noreen Shaikh |
|---|---|
| Gender | Female |
| Speciality | Ophthalmology |
| Experience | 8 Years |
| Location | 1 Essex Center Dr, Peabody, Massachusetts |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1740644012 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 282769 (Massachusetts) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Monmouth Retina Consultants Pa | 2860492170 | 12 |
News Archive
Lifetime discrimination is a chronic stressor that may increase the risk for hypertension also known as high blood pressure, in African Americans, according to new research published today in Hypertension, an American Heart Association journal.
A new study has revealed that men hoping to conceive should stop drinking for at least six months before to prevent congenital heart diseases.
Scientists from the Barbara Ann Karmanos Cancer Institute and Wayne State University School of Medicine (WSU SOM) in Detroit will present the world's largest study that shows the long-term results of fast neutron radiotherapy (FNRT) in the treatment of localized prostate cancer. The findings will be formally announced Tuesday, Nov. 2, at the American Society of Therapeutic Radiology and Oncology (ASTRO) Annual Meeting
A team of investigators at The Cancer Institute of New Jersey (CINJ); Rutgers, The State University of New Jersey; and Princeton University, have determined that cancer cells are "addicted" to a self-preservation process known as autophagy. They also showed that the inhibition of that process could prove to be a valuable treatment approach for aggressive cancers. CINJ is a Center of Excellence of UMDNJ-Robert Wood Johnson Medical School.
The U.S. Patent and Trademark Office has approved Advaxis, Inc.,the live, attenuated Listeria monocytogenes (Listeria) immunotherapy company, intellectual property protection to patent application 11/223,945 - a live, attenuated Listeria vaccine that secretes novel fragments of the tumor antigen HER2/neu (human epidermal growth factor receptor 2), when using the company's proprietary listeriolysin O (LLO) fusion platform technology.
› Verified 6 days ago
| Entity Name | Monmouth Retina Consultants Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437179942 PECOS PAC ID: 2860492170 Enrollment ID: O20070111000161 |
News Archive
Lifetime discrimination is a chronic stressor that may increase the risk for hypertension also known as high blood pressure, in African Americans, according to new research published today in Hypertension, an American Heart Association journal.
A new study has revealed that men hoping to conceive should stop drinking for at least six months before to prevent congenital heart diseases.
Scientists from the Barbara Ann Karmanos Cancer Institute and Wayne State University School of Medicine (WSU SOM) in Detroit will present the world's largest study that shows the long-term results of fast neutron radiotherapy (FNRT) in the treatment of localized prostate cancer. The findings will be formally announced Tuesday, Nov. 2, at the American Society of Therapeutic Radiology and Oncology (ASTRO) Annual Meeting
A team of investigators at The Cancer Institute of New Jersey (CINJ); Rutgers, The State University of New Jersey; and Princeton University, have determined that cancer cells are "addicted" to a self-preservation process known as autophagy. They also showed that the inhibition of that process could prove to be a valuable treatment approach for aggressive cancers. CINJ is a Center of Excellence of UMDNJ-Robert Wood Johnson Medical School.
The U.S. Patent and Trademark Office has approved Advaxis, Inc.,the live, attenuated Listeria monocytogenes (Listeria) immunotherapy company, intellectual property protection to patent application 11/223,945 - a live, attenuated Listeria vaccine that secretes novel fragments of the tumor antigen HER2/neu (human epidermal growth factor receptor 2), when using the company's proprietary listeriolysin O (LLO) fusion platform technology.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Noreen Shaikh, MD 1 Essex Center Dr, Peabody, MA 01960-2901 Ph: (978) 538-4620 | Noreen Shaikh, MD 1 Essex Center Dr, Peabody, MA 01960-2901 Ph: (978) 538-4400 |
News Archive
Lifetime discrimination is a chronic stressor that may increase the risk for hypertension also known as high blood pressure, in African Americans, according to new research published today in Hypertension, an American Heart Association journal.
A new study has revealed that men hoping to conceive should stop drinking for at least six months before to prevent congenital heart diseases.
Scientists from the Barbara Ann Karmanos Cancer Institute and Wayne State University School of Medicine (WSU SOM) in Detroit will present the world's largest study that shows the long-term results of fast neutron radiotherapy (FNRT) in the treatment of localized prostate cancer. The findings will be formally announced Tuesday, Nov. 2, at the American Society of Therapeutic Radiology and Oncology (ASTRO) Annual Meeting
A team of investigators at The Cancer Institute of New Jersey (CINJ); Rutgers, The State University of New Jersey; and Princeton University, have determined that cancer cells are "addicted" to a self-preservation process known as autophagy. They also showed that the inhibition of that process could prove to be a valuable treatment approach for aggressive cancers. CINJ is a Center of Excellence of UMDNJ-Robert Wood Johnson Medical School.
The U.S. Patent and Trademark Office has approved Advaxis, Inc.,the live, attenuated Listeria monocytogenes (Listeria) immunotherapy company, intellectual property protection to patent application 11/223,945 - a live, attenuated Listeria vaccine that secretes novel fragments of the tumor antigen HER2/neu (human epidermal growth factor receptor 2), when using the company's proprietary listeriolysin O (LLO) fusion platform technology.
› Verified 6 days ago
Fina Canas Barouch, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1 Essex Center Dr, Lahey Clinic, Peabody, MA 01960 Phone: 978-538-4400 Fax: 978-538-4724 | |
William B Orenberg, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 31 Centennial Dr, Peabody, MA 01960 Phone: 978-531-4400 | |
Susan Mary Tucker, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1 Essex Center Dr, Lahey Clinic, Peabody, MA 01960 Phone: 978-538-4400 Fax: 978-538-4724 | |
Richard C Rodman, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 31 Centennial Dr, Peabody, MA 01960 Phone: 978-531-4400 | |
Jeffrey A Sorkin, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 31 Centennial Dr, Peabody, MA 01960 Phone: 978-531-4400 | |
Shiyoung Roh, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1 Essex Center Dr, Peabody, MA 01960 Phone: 978-538-4430 Fax: 781-744-5215 |